Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03512015 | A Mobile Supportive Care App for Patients With Metastatic Lung Cancer(LuCApp) | unknown | N/A | 120 | Bocconi UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT02884479 | An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study | unknown | Phase 1 / Phase 2 | 75 | SciClone Pharmaceuticals International (Cayman) Development Limited |
| 1 |
| Apr 25, 2018 |
| clinicaltrials |
| NCT02134990 | Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer | unknown | Phase 2 | 20 | Oshadi Drug AdministrationINDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT03489616 | Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients(CRAGMOLC) | unknown | N/A | 45 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT03486496 | Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation(Geber) | unknown | Phase 2 | 50 | Fujian Cancer HospitalOTHER_GOV | 1 | Apr 3, 2018 | clinicaltrials |
| NCT03471884 | Effects of Nonintubated Thoracoscopic Lobectomy on Lung Protection | unknown | N/A | 82 | National Taiwan University HospitalOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT02758587 | Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) | unknown | Phase 1 / Phase 2 | 59 | NHS Greater Glasgow and ClydeOTHER | 1 | Mar 19, 2018 | clinicaltrials |
| NCT03464032 | A Study of BCD-135 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 30 | BiocadINDUSTRY | 1 | Mar 13, 2018 | clinicaltrials |
| NCT03460275 | Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer | unknown | Phase 2 | 100 | Sun Yat-sen UniversityOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT03461185 | Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer | unknown | Phase 2 | 100 | Xinqiao Hospital of ChongqingOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT02778854 | Liquid Biopsy for Detection of Driver Mutation in NSCLC | unknown | — | 200 | Chinese PLA General HospitalOTHER | 1 | Mar 8, 2018 | clinicaltrials |
| NCT03453307 | Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients | unknown | — | 100 | K2 Oncology, Inc.INDUSTRY | 1 | Mar 5, 2018 | clinicaltrials |
| NCT01102517 | A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer | unknown | N/A | 500 | Sun Yat-sen UniversityOTHER | 1 | Feb 28, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03446911 | Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery | unknown | Phase 1 / Phase 2 | 20 | Amsterdam UMC, location VUmcOTHER | 0 | Feb 27, 2018 | clinicaltrials |
| NCT03432637 | Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia | unknown | Phase 3 | 450 | Guangzhou Institute of Respiratory DiseaseOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT03427541 | A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases | unknown | — | 1,000 | Tang-Du HospitalOTHER | 1 | Feb 9, 2018 | clinicaltrials |
| NCT03424759 | Uncommon EGFR AZD9291 | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT02151721 | Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer(VICTORY-J) | unknown | Phase 1 | 12 | Kanazawa UniversityOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT03416231 | Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC) | unknown | Phase 2 | 20 | Affiliated Hospital of North Sichuan Medical CollegeOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03416972 | Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy(RICT-LUNG) | unknown | — | 20 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03413358 | Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral Liquid | unknown | N/A | 240 | BeiJing Yijiayi Medicine Techonoloy Co., Ltd.INDUSTRY | 1 | Jan 29, 2018 | clinicaltrials |
| NCT02734524 | A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer | unknown | Phase 2 | 104 | Southwest Hospital, ChinaOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02852083 | A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC(ModuLung) | unknown | Phase 2 | 86 | University Hospital RegensburgOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02934360 | TR(ACE) Assay Clinical Specimen Study | unknown | — | 450 | Biological DynamicsINDUSTRY | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03127319 | A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases | unknown | Phase 2 | 40 | Affiliated Hospital of Hebei UniversityOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT03399669 | The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation | unknown | Phase 2 | 100 | Samsung Medical CenterOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT02410369 | Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer | unknown | Phase 2 | 60 | Tokyo UniversityOTHER | 1 | Dec 21, 2017 | clinicaltrials |
| NCT03376191 | Apatinib in Advanced Non-squamous，NSCLC | unknown | — | 100 | Jian FangOTHER | 1 | Dec 18, 2017 | clinicaltrials |
| NCT03376737 | Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma | unknown | Phase 2 | 120 | Henan Cancer HospitalOTHER_GOV | 1 | Dec 18, 2017 | clinicaltrials |
| NCT03201146 | Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC | unknown | Phase 1 / Phase 2 | 48 | West China HospitalOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT03341494 | EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide | unknown | Phase 2 | 128 | Fujian Cancer HospitalOTHER_GOV | 1 | Nov 14, 2017 | clinicaltrials |
| NCT03262948 | Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer | unknown | Phase 3 | 388 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 0 | Nov 13, 2017 | clinicaltrials |
| NCT02397239 | Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer | unknown | — | 72 | National Cheng-Kung University HospitalOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT03331575 | Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC(HCFCCUSN) | unknown | Phase 3 | 480 | Shanghai Chest HospitalOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02714010 | EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC | unknown | Phase 3 | 601 | Sun Yat-sen UniversityOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT02499614 | Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS)(METROS) | unknown | Phase 2 | 80 | Fondazione Ricerca TraslazionaleOTHER | 1 | Oct 25, 2017 | clinicaltrials |
| NCT03198923 | Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer | unknown | Phase 1 | 30 | Wenxiang WangOTHER | 1 | Sep 25, 2017 | clinicaltrials |
| NCT02455843 | Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC | unknown | Phase 3 | 275 | Shandong Provincial HospitalOTHER_GOV | 1 | Sep 19, 2017 | clinicaltrials |
| NCT02894853 | Lung Cancer Early Molecular Assessment Trial(LEMA) | unknown | — | 1,297 | The Netherlands Cancer InstituteOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT03269162 | Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection | unknown | Phase 3 | 144 | lihegenOTHER | 0 | Sep 14, 2017 | clinicaltrials |
| NCT03282435 | Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody | unknown | Phase 1 | 30 | Dalian UniversityOTHER | 0 | Sep 14, 2017 | clinicaltrials |
| NCT03264794 | the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer) | unknown | Phase 4 | 100 | Jiangsu Famous Medical Technology Co., Ltd.INDUSTRY | 0 | Aug 29, 2017 | clinicaltrials |
| NCT03258671 | IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer | unknown | N/A | 160 | LuBingOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT02423590 | Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers | unknown | Phase 2 | 140 | Queen Mary University of LondonOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02515435 | The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Aug 18, 2017 | clinicaltrials |
| NCT03065764 | 89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer | unknown | Phase 2 | 10 | Amsterdam UMC, location VUmcOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT02404675 | High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation(INCREASE) | unknown | Phase 4 | 240 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 28, 2017 | clinicaltrials |
| NCT03228368 | The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC Patients | unknown | — | 10 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Jul 24, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Apr 30, 2018source: clinicaltrials